WALTHAM, Mass., Dec. 6 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming 2007 RBC Capital Markets Healthcare Conference being held December 12, 2007 at The Westin Times Square, New York City. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Mr. Zwanziger will participate in a one-hour panel discussion after presenting a brief summary of the company's business. The presentation and panel discussion are scheduled for Wednesday, December 12, 2007 at 2:30 p.m. and will be made available to the public through an audio webcast accessible through the company's website at http://www.invmed.com/investors.cfm and Wall Street Webcasting's website at http://www.wsw.com/webcast/rbc84/panel14. A replay of the webcast will be available via the links above for 30 days. During the presentation and panel discussion, Mr. Zwanziger or Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
Prior to the conference the Company will also be posting an updated investor presentation on its website at http://www.invmed.com/presentations.cfm.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
|SOURCE Inverness Medical Innovations, Inc.|
Copyright©2007 PR Newswire.
All rights reserved